Evaluating the Diagnostic Accuracy of Point-of-Care CXCL13 Measurements for Lyme Neuroborreliosis

<b>Background</b>: Measurements of the B-cell attracting chemokine CXCL13 in cerebrospinal fluid (CSF) has become increasingly popular in the diagnostic work-up for Lyme neuroborreliosis (LNB). ReaScan is a point-of-care test for CXCL13 with a short turnaround-time. However, the diagnostic cut-off v...

Description complète

Détails bibliographiques

Auteurs principaux:	Lasse Fjordside, Mathilde Ørbæk, Thomas Bryrup, Louise Helvig Kaas, Alex Christian Yde Nielsen, Nikolai Søren Kirkby, Helene Mens, Anne-Mette Lebech
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2026-05-01
Collection:	Diagnostics
Sujets:	Lyme neuroborreliosis biomarkers CXCL13 diagnostics
Accès en ligne:	https://www.mdpi.com/2075-4418/16/10/1424
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!